More than a common acid buffering in the treatment of Non-Erosive GERD-like Clinical Spectrum: A Chios Masthia-based Formulation with (Cyto) Protecting Effect
Open Access
- 26 February 2019
- journal article
- Published by Peertechz Publications Private Limited in Archives of Clinical Gastroenterology
- Vol. 5 (1), 003-010
- https://doi.org/10.17352/2455-2283.000060
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux diseaseGut, 2012
- Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux diseaseHealth and Quality of Life Outcomes, 2010
- Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- In Vitro and In Vivo Activities of Chios Mastic Gum Extracts and Constituents against Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 2007
- Rome III: The new criteriaChinese Journal of Digestive Diseases, 2006
- Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory functionGut, 2005
- Mastic gum has no effect on Helicobacter pylori load in vivoJournal of Antimicrobial Chemotherapy, 2003
- Functional esophageal disordersGut, 1999
- Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNFCytokine, 1989
- A DOUBLE‐BLIND CONTROLLED CLINICAL TRIAL OF MASTIC AND PLACEBO IN THE TREATMENT OF DUODENAL ULCERClinical and Experimental Pharmacology and Physiology, 1984